Novo Nordisk A Fs reported DKK38.37B in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Ani Pharmaceuticals ANIP:US USD 50.93M 12.37M
Aurora Cannabis Inc ACB:CN CAD -22824000 580K
Bristol Myers Squibb BMY:US USD 8.86B 345M
Canopy Growth Corp WEED:CN CAD 3.82M 5.21M
Catalent CTLT:US USD 258M 230M
Corcept Therapeutics CORT:US USD 100.39M 1.68M
Eli Lilly And LLY:US USD 5.36B 305M
Endo International Ordinary Shares ENDP:US USD 364.83M 28.49M
GlaxoSmithKline GSK:LN GBP 5.44B 650M
Horizon Pharma HZNP:US USD 691.23M 45.03M
Lannett LCI:US USD 12.6M 4.74M
Merk MRK:US USD 11.52B 1.08B
Nektar Therapeutics NKTR:US USD 18.65M 2.18M
Novartis NOVN:VX USD 9.18B 151M
Novo Nordisk A Fs NVO:US DKK 38.37B 3.17B
Pacira Pharmaceuticals PCRX:US USD 116.79M 2M
Perrigo Ordinary Shares PRGO:US USD 362.9M 9.2M
Prestige Brands PBH:US USD 161.01M 890K
Teva Pharmaceutical Industries TEVA:US USD 1.71B 118M
Valeant Pharmaceuticals VRX:CN USD 1.46B 72M
Zoetis ZTS:US USD 1.4B 36M